XOMA Royalty (XOMA) Revenue (2011 - 2026)
XOMA Royalty (XOMA) reported Revenue of $12.3 million for Q1 2026, up 207.95% on a YoY basis from $4.0 million in Q1 2025, and down 10.46% sequentially from $13.8 million in Q4 2025.
XOMA Royalty (XOMA) Revenue (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Revenue data on file, last reported at $12.3 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 207.95% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $35.1 million (up 109.9% YoY), and the FY2025 full-year result was $52.1 million, up 684.2% from the prior year.
- Revenue slipped to $12.3 million in Q1 2026, from $13.8 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $13.8 million in Q4 2025 to a low of $225000.0 in Q3 2023.
- A 5-year average of $3.6 million and a median of $1.6 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue slumped 84.11% in 2023 and surged 3098.67% in 2024, its largest moves.
- Tracing XOMA's Revenue over 5 years: stood at $850000.0 in 2022, then soared by 52.94% to $1.3 million in 2023, then tumbled by 61.54% to $500000.0 in 2024, then surged by 2651.4% to $13.8 million in 2025, then declined by 10.46% to $12.3 million in 2026.
- Business Quant data shows XOMA's Revenue at $12.3 million in Q1 2026, $13.8 million in Q4 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.32 Mn |
| Dec 31, 2025 | 13.76 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 5.03 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 850,000.00 |
| Sep 30, 2022 | 451,000.00 |
| Jun 30, 2022 | 525,000.00 |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 550,000.00 |
| Jun 30, 2021 | 901,000.00 |
| Mar 31, 2021 | 375,000.00 |